ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Rhode Island » Internal Medicine

Top Internal Medicine Prescribers in Rhode Island

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SHAHZAD KHURSHID M.D.

Internal Medicine

32,309

$1.75M

643
566 are 65+

18%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $51

EDWARD GAUTHIER M.D.

Internal Medicine

19,364

$945K

334
313 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $51

BASSAM KHABBAZ MD

Internal Medicine

15,590

$888K

301
275 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $51

WILLIAM BELIVEAU MD

Internal Medicine

17,678

$867K

675
600 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $51

RINCHEN-TZO EMGUSHOV MD

Internal Medicine

5,684

$787K

228
174 are 65+

N/A

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 22%

$138
Average prescription price

Avg: $51

ALLEN DENNISON M.D.

Internal Medicine

9,933

$644K

460
399 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$65
Average prescription price

Avg: $51

CLAUDE YOUNES M.D.

Internal Medicine

7,974

$599K

387
308 are 65+

N/A

4%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 22%

$75
Average prescription price

Avg: $51

DANIEL HOCHBERGER M.D.

Internal Medicine

6,111

$550K

274
242 are 65+

N/A

4%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 22%

$90
Average prescription price

Avg: $51

STEVEN BRIN MD

Internal Medicine

8,544

$483K

418
361 are 65+

N/A

6%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

JOHN BERGERON MD

Internal Medicine

8,496

$457K

469
296 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $51

R GILLIE MD

Internal Medicine

9,249

$439K

389
359 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $51

DONALD HEBB MD

Internal Medicine

8,118

$403K

384
329 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $51

VITO LONGOBARDI M.D.

Internal Medicine

5,892

$398K

311
238 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$68
Average prescription price

Avg: $51

TIMOTHY O'MARA M.D.

Internal Medicine

5,847

$300K

396
307 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $51

DANIEL GUEVARA-PINEDA M.D

Internal Medicine

4,210

$265K

220
142 are 65+

N/A
N/A

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $51

SERGIO RODRIGUEZ SERRANO M.D.

Internal Medicine

5,171

$258K

221
146 are 65+

N/A
N/A

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $51

HEIDI DORRIS M.D.

Internal Medicine

4,319

$215K

196
148 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $51

TONY WU M.D.

Internal Medicine

4,572

$198K

299
252 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$43
Average prescription price

Avg: $51

FLORA TREGER MD

Internal Medicine

4,208

$180K

259
220 are 65+

N/A
N/A

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$43
Average prescription price

Avg: $51

ELAINE FAIN MD

Internal Medicine

2,722

$136K

172
157 are 65+

N/A
N/A

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $51

DAVID HEREC MD

Internal Medicine

3,395

$129K

176
154 are 65+

N/A
N/A

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$38
Average prescription price

Avg: $51

HAO HUANG M.D.

Internal Medicine

77,745

$4.15M

1350
1175 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $51

RICHARD RUGGIERI M.D.

Internal Medicine

34,402

$1.78M

1113
901 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $51

AVANISH MEHTA M.D.

Internal Medicine

27,797

$1.56M

452
387 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

RALPH SANTORO M.D.

Internal Medicine

29,193

$1.51M

693
610 are 65+

20%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $51

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank